A 48-year-old man with newly diagnosed type 2 diabetes (HbA1c 8.4%) and BMI 32 kg/m² has no cardiovascular disease or CKD. You decide to start pharmac...

Question

A 48-year-old man with newly diagnosed type 2 diabetes (HbA1c 8.4%) and BMI 32 kg/m² has no cardiovascular disease or CKD. You decide to start pharmacologic therapy. According to current Diabetes Canada guidance, what is the preferred initial antihyperglycaemic agent for most people like him?

Accepted Answer

Metformin

Answer

Basal insulin

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

SGLT2 inhibitor

ca-mccqe1 MCQ (SBA): Type 2 diabetes pharmacologic initiation

A 48-year-old man with newly diagnosed type 2 diabetes (HbA1c 8.4%) and BMI 32 kg/m² has no cardiovascular disease or CKD. You decide to start pharmacologic therapy. According to current Diabetes Canada guidance, what is the preferred initial antihyperglycaemic agent for most people like him?